New Publication Validates Triaging Tool for COVID Patients
Immunexpress detailed a study that validated the use of its SeptiCyte RAPID as a triaging tool for COVID patients requiring hospitalization.
Read MorePosted by Andy Lundin | Feb 3, 2023 | Covid 19 |
Immunexpress detailed a study that validated the use of its SeptiCyte RAPID as a triaging tool for COVID patients requiring hospitalization.
Read MorePosted by Andy Lundin | Feb 3, 2023 | Disease States |
The NCCHD in Japan and OmniTier detailed how the company’s genomic analysis platform improved diagnostic rates for rare diseases.
Read MorePosted by Andy Lundin | Feb 1, 2023 | Immunoassay Reagents & test Kits, Lung Cancer |
OncoHost, a diagnostics company centered on predictive biomarker development patient care, launched its non-small lung cancer (NSCLC) test.
Read MorePosted by Andy Lundin | Jan 30, 2023 | Covid 19 |
New machine learning research provides a way to predict if respiratory symptoms are caused by COVID, influenza, or RSV.
Read MorePosted by Andy Lundin | Jan 27, 2023 | Infectious Diseases, Point-of-Care |
A new study shows the benefits of using a quick clinic-based diagnostic test for hepatitis C virus infection over a standard lab-based test.
Read More